Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma

被引：0
|
作者：
Falcone, Umberto [1 ,2 ]
Jiang, Haiyan [3 ]
Bashir, Shaheena [3 ]
Tsang, Richard [4 ]
Kukreti, Vishal [1 ,2 ]
Keating, Armand [1 ,2 ]
Crump, Michael [1 ,2 ]
Kuruvilla, John [1 ,2 ]
机构：
[1] Univ Toronto, Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
[3] Univ Toronto, Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada
[4] Univ Toronto, Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷 / 03期
关键词：
PROSPECTIVE RANDOMIZED-TRIAL; PLUS RITUXIMAB; FREE SURVIVAL; CYCLOPHOSPHAMIDE; CHEMOTHERAPY; SUPERIOR; THERAPY; CHOP;
D O I：
10.1038/s41409-017-0054-8
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：347 / 351
页数：5
相关论文
共 50 条
  • [21] A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma
    Gressin, Remy
    Daguindau, Nicolas
    Tempescul, Adrian
    Moreau, Anne
    Carras, Sylvain
    Tchernonog, Emmanuelle
    Schmitt, Anna
    Houot, Roch
    Dartigeas, Caroline
    Pignon, Jean Michel
    Corm, Selim
    Banos, Anne
    Mounier, Christiane
    Dupuis, Jehan
    Macro, Margaret
    Fleury, Joel
    Jardin, Fabrice
    Sarkozy, Clementine
    Damaj, Ghandi
    Feugier, Pierre
    Fornecker, Luc Matthieu
    Chabrot, Cecile
    Dorvaux, Veronique
    Bouadallah, Krimo
    Amorin, Sandy
    Garidi, Reda
    Voillat, Laurent
    Joly, Bertrand
    Celigny, Philippe Solal
    Morineau, Nadine
    Moles, Marie Pierre
    Zerazhi, Hacene
    Fontan, Jean
    Arkam, Yazid
    Alexis, Magda
    Delwail, Vincent
    Vilque, Jean Pierre
    Ysebaert, Loic
    Le Gouill, Steven
    Callanan, Mary B.
    HAEMATOLOGICA, 2019, 104 (01) : 138 - 146
  • [22] R-CHOP or R-HyperCVAD With or Without Autologous Stem Cell Transplantation for Older Patients With Mantle Cell Lymphoma
    Frosch, Zachary
    Luskin, Marlise R.
    Landsburg, Daniel J.
    Schuster, Stephen J.
    Svoboda, Jakub
    Loren, Alison W.
    Porter, David L.
    Stadtmauer, Edward A.
    Nasta, Sunita D.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (02) : 92 - 97
  • [23] The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma
    Cakar, Merih K.
    Tekgunduz, Emre
    Dal, Mehmet S.
    Merdin, Alparslan
    Basci, Semih
    Iskender, Dicle
    Ugur, Bilge
    Bekdemir, Filiz
    Yildiz, Jale
    Ulu, Bahar U.
    Bakirtas, Mehmet
    Yigenoglu, Tugce N.
    Batgi, Hikmetullah
    Kaya, Ali H.
    Altuntas, Fevzi
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (02) : 273 - 278
  • [24] Autologous Stem Cell Transplantation as the First-Line Treatment for Peripheral T Cell Lymphoma: Results of a Comprehensive Meta-Analysis
    Yin, J.
    Wei, J.
    Xu, J. H.
    Xiao, Y.
    Zhang, Y. C.
    ACTA HAEMATOLOGICA, 2014, 131 (02) : 114 - 125
  • [25] Autologous hematopoietic cell transplantation of mantle cell lymphoma: emerging trends
    Falcone, Umberto
    Kuruvilla, John
    CURRENT OPINION IN HEMATOLOGY, 2017, 24 (06) : 502 - 508
  • [26] Impact of Pre-transplant Rituximab on Survival after Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B Cell Lymphoma
    Fenske, Timothy S.
    Hari, Parameswaran N.
    Carreras, Jeanette
    Zhang, Mei-Jie
    Kamble, Rammurti T.
    Bolwell, Brian J.
    Cairo, Mitchell S.
    Champlin, Richard E.
    Chen, Yi-Bin
    Freytes, Cesar O.
    Gale, Robert Peter
    Hale, Gregory A.
    Ilhan, Osman
    Khoury, H. Jean
    Lister, John
    Maharaj, Dipnarine
    Marks, David I.
    Munker, Reinhold
    Pecora, Andrew L.
    Rowlings, Philip A.
    Shea, Thomas C.
    Stiff, Patrick
    Wiernik, Peter H.
    Winter, Jane N.
    Rizzo, J. Douglas
    van Besien, Koen
    Lazarus, Hillard M.
    Vose, Julie M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (11) : 1455 - 1464
  • [27] Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403
    Kaplan, Lawrence D.
    Maurer, Matthew J.
    Stock, Wendy
    Bartlett, Nancy L.
    Fulton, Noreen
    Pettinger, Adam
    Byrd, John C.
    Blum, Kristie A.
    LaCasce, Ann S.
    Hsi, Eric D.
    Liu, Yi Tian
    Scott, David W.
    Hurd, David
    Ruppert, Amy S.
    Hernandez-Ilizaliturri, Francisco
    Leonard, John P.
    Cheson, Bruce D.
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (06) : 583 - 593
  • [28] Effectiveness of first line treatment with bortezomib prior to autologous stem cell transplantation for multiple myeloma
    Cernelc, Peter
    Kodre, Veronika
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2012, 81 (04): : 304 - 311
  • [29] High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era
    Ban-Hoefen, Makiko
    Kelly, Jennifer L.
    Bernstein, Steven H.
    Liesveld, Jane
    Constine, Louis
    Becker, Michael
    Milner, Laurie
    Phillips, Gordon
    Friedberg, Jonathan W.
    LEUKEMIA & LYMPHOMA, 2012, 53 (05) : 830 - 835
  • [30] Comparative Effectiveness of Chemotherapy, Rituximab, and Bendamustine in Medicare Beneficiaries With Mantle-Cell Lymphoma
    Fu, Shuangshuang
    Wang, Michael
    Zhao, Hui
    Li, Ruosha
    Lairson, David R.
    Giordano, Sharon H.
    Zhao, Bo
    Du, Xianglin L.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (11) : E616 - E623
12345